NBSE - NeuBase Therapeutics down 11% after pricing equity offering April, 28 2020 09:58 AM NeuBase Therapeutics Inc. NeuBase Therapeutics (NBSE -11.4%) has priced its public offering of 5.25M common shares at $6/share.More news on: NeuBase Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...